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Prognostic value of 12-lead electrocardiogram and
peak troponin I level after vascular surgery
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Edward O. McFalls, MD, PhD,a Minneapolis, Minn
Objective: The aim of this investigation was to determine if the presence of ischemic electrocardiographic (ECG) changes
in patients undergoing vascular surgery provides incremental prognostic information about the long-term risk of death
compared with a single peak troponin level within 48 hours after surgery.
Methods: This was a retrospective analysis of 337 patients undergoing moderate-risk to high-risk vascular surgery at our
institution whose ECG and biomarker data were complete. Peak cardiac troponin (cTn) I values that exceeded the upper
reference limit (URL) were categorized as low-positive (), at or exceeding the URL but less than three times the URL,
or high-positive (), at or exceeding three times the URL. ECGs were classified as ischemic or nonischemic. The primary
outcome was death at 1 year after the vascular operation. Independent predictors of long-termmortality were determined
by Cox proportional hazards regression analysis.
Results: The most common vascular problem was an expanding abdominal aortic aneurysm (n 185 [55%]). With regard
to cTnI, 53 patients (16%) were classified as high () and 82 (24%) as low (). The ECG in 21 patients (6%) showed
evidence of myocardial ischemia. An increase in 1-year mortality of 3% for normal, 11% for low (), and 17% for high ()
(P < .01) was seen with incremental cTn values. Independent predictors of long-term mortality were age (odds ratio
[OR], 1.05, 95% confidence interval [CI], 1.02-1.07; P < .01), stratified troponin (OR, 1.62; 95% CI, 1.25-2.10; P <
.01), tissue loss (OR, 3.30; 95% CI, 1.72-6.33; P < .01), stratified Revised Cardiac Risk Index (OR, 1.32; 95% CI,
0.97-1.81; P < .07), and statin use (OR, 0.62; 95% CI, 0.40-0.98; P  .04). The presence of ischemia on ECG was not
a predictor of long-term mortality.
Conclusions: In the presence of an elevated cTn I, the ECG is not an independent predictor of long-term mortality after
vascular surgery. These results support a strategy of routine surveillance of cTns after vascular surgery for the detection
of cardiac events and postoperative risk stratification. (J Vasc Surg 2013;57:166-72.)
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sThe electrocardiogram (ECG) is considered an essen-
tial component of the diagnostic evaluation of a suspected
myocardial infarction (MI), as recommended by a joint
European Society of Cardiology/American College of Car-
diology Foundation/American Heart Association/World
Heart Federation Task Force.1 This is particularly relevant
after noncardiac operations, where patients are heavily se-
dated and episodes of myocardial ischemia remain subclin-
ical.2-5 Although 24-hour ECG monitoring may increase
the capacity to diagnose transient myocardial ischemic
events, the technology may be insensitive to many pa-
tients,2,6 including those individuals who ultimately are
diagnosed with a postoperative MI.7,8 It is not surprising
that clinicians rely on a rise and fall of specific cardiac
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166iomarkers in the first several days after surgery as a means
f optimal risk stratification in the postoperative period.2,7
Cardiac troponin (cTn) has gained widespread accep-
ance as a highly sensitive and specific biomarker of myo-
ardial necrosis.6,9,10 After a noncardiac operation, an ele-
ated cTn level is an identifier of increased mortality6-11
nd, as shown in a recent meta-analysis, independently
redicts long-term risk of death.12 Although the presence
f new ECG changes has been used as a means of adjudi-
ating the presence or absence of an MI in patients with an
levated troponin level,1,3 no study has tested the indepen-
ent value of the ECG beyond that offered by the specific
roponin elevation. Accordingly, in this study, we tested
hether the presence of ischemic ECG changes in patients
ndergoing high-risk vascular surgery, provides incremen-
al prognostic information about the long-term risk of
eath compared with a single peak troponin level 48
ours after surgery.
ETHODS
This study was approved by the Human Studies Com-
ittee and the Research and Development Committee of
he Minneapolis Veterans Affairs Medical Center. Individ-
al consent was waived.
Study patients. Between January 2005 and Decem-
er 2009, 545 consecutive patients underwent vascular
urgery at the Minneapolis VA Medical Center, and their
elevant clinical and surgical variables were collected in a
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Volume 57, Number 1 Garcia et al 167database. The study cohort for the present retrospective
analysis comprised 337 patients (61% of total) who under-
went a qualifying vascular operation during the study pe-
riod. Qualifying vascular operations included endovascular
(EVAR) and open abdominal aortic repairs, lower limb
revascularization, and carotid endarterectomy. All proce-
dures, including EVAR, were performed under general
anesthesia. We excluded 96 patients with incomplete bio-
marker or ECG data and 112 patients who underwent
amputations or lower-risk percutaneous revascularization
procedures such as carotid or lower limb stenting.
Patients’ clinical risk scores were estimated by quanti-
fying the Revised Cardiac Risk Index (RCRI).13 Briefly, the
RCRI is calculated by giving a score of 0 (absent) or 1
(present) to the following clinical variables: history of cor-
onary artery disease, insulin-dependent diabetes, history of
congestive heart failure, history of cerebrovascular disease,
high-risk surgery, and renal insufficiency (creatinine 2
mg/dL).
Troponin assays andmyocardial perfusion imaging.
Blood samples were obtained in all patients48 hours after
surgery, and troponin I levels were determined by the Dade
Behring Dimension Analyzer (Siemens Healthcare Diag-
nostics Inc, Tarrytown, NY). The peak troponin I level was
considered abnormal if it exceeded the upper reference
limit (URL), based on the 99th percentile of a normal
population, as specified by the manufacturer guidelines.
The lower limit of detection was 0.03 g/L, and the 20%
and 10% total imprecision were determined at 0.1 and 0.3
g/L, respectively.14 Values were categorized as low-
positive (low []) at or exceeding the URL but less than
three times the URL, or high-positive (high []) at three
or more times the URL. This analytic strategy has been
published before.15
When available, each single-photon emission com-
puted tomography (SPECT) imaging test with a myocar-
dial perfusion defect was visually semiquantitated. Defect
size was determined by polar map analysis and categorized
according to the percentage of the left ventricular wall
involved as small, 10%; medium, 10% to 20%; and large,
20%.
Twelve-lead ECG. A 12-lead ECG was obtained
before the operation and daily for 3 postoperative days.
Two board-certified cardiologists (S.G., G.P.), who were
blinded to the troponin values and clinical outcomes, re-
viewed the ECG tracings and classified them as ischemic
(ST-segment depression1 mm, or2 mm T-wave inver-
sion in at least contiguous leads) or nonischemic. In the
event of a paced rhythm or left bundle branch block,
tracings were deemed uninterpretable and the ECG was
designated as nondiagnostic. The interobserver agreement
rate for ECG reading was 93%. In cases where a discordant
reading was present, the senior cardiologist reading (G.P.)
provided the analysis.
Outcome. The primary outcome was death at 1 year
after the vascular operation. Survival was determined from
the time of the vascular operation, and deaths were re-
trieved through the Department of Veterans Affairs Bene- hciary Information and Electronic Records Locator Subsys-
em. Secondary outcomes included 30-day and 2.5-year
ortality.
Statistics. Data are presented as mean  standard
eviation or as percentages. Continuous variables were
ompared with the t-test when normally distributed and by
nonparametric test when skewed. Categoric variables
ere compared with 2 test. Predictors of the long-term
isk of death were determined by Cox proportional hazards
egression analysis with backward elimination. A Cox re-
ression analysis model was used to analyze univariate
linical variables that were associated with increased mor-
ality at 1 year (P  .05) and variables associated with
ncreased mortality risk in other studies, including preop-
rative cardiac risk, as estimated by the RCRI (three or
ore risks),13,16 advanced arterial-occlusive disease, de-
ned by tissue loss with nonhealing ulcers,17,18 high-risk
ascular surgery involving abdominal operations with aortic
ross-clamp,19 presence of ischemic ECG changes,8 peak
ostoperative troponin levels (three ormore times theURL
f the specific troponin assay),1,15 age, and preoperative
tatin treatment.20 Individual risk factors included in the
CRI were not included. Survival curves were generated
sing the product-limit method, and intergroup differences
ere evaluated using the log-rank test. Odds ratios (OR)
nd hazard ratios (HRs) with their respective 95% confi-
ence intervals (CI) are presented. Differences for all tests
ere considered significant at P  .05. SPSS 11 software
SPSS Inc, Chicago, Ill) was used for statistical analysis.
ESULTS
Study cohort. A total of 337 patients underwent vas-
ular surgery, and one or more troponin values were drawn
48 hours of surgery in all patients. The mean age of the
opulation was 69 8 years, and the mean RCRI was 2
.8. An expanding abdominal aneurysm was present in 185
atients (55%), which was the most common indication for
ascular surgery. Other indications were severe symptom-
tic carotid artery disease in 77 (23%) and critical limb
schemia, including severe claudication in 20 (6%), rest pain
n 22 (6.5%), and nonhealing ulcers or tissue loss in 20
6%). Preoperative medication use included aspirin in 76%,
-blockers in 73%, and statins in 71%.
Elevated postoperative troponin levels and outcomes.
roponin levels exceeded the URL of the assay in 135
atients; of whom, 53 (16%) were classified as high () and
2 (24%) as low (). Of those patients with an elevated
evel, nearly 90% had a rise and fall of the troponin I level
hat was 30% of the baseline value, consistent with a
erioperative cardiac event. As reported in Table I, those
atients with an elevated cTn level were older, had a
igher preoperative RCRI, and were more likely to have
moderate to large perfusion defect on SPECT before
he operation.
An elevated troponin level predicted increased risk of
eath (Fig 1; Table II). Compared with those patients with
negative postoperative cTn, patients with a low () and a
igh () cTn level had an increased risk of death at 1 year
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(7% vs 16% vs 28%; P .01; Table II) after vascular surgery.
Use of cardiac medications during long-term follow-up was
high, including aspirin in 86%, -blockers in 74.5%, and
statins in 71%. Among diabetic patients, the mean glycated
hemoglobin was 6.63%  1.37%.
Postoperative ECG changes and outcomes. New
ischemic changes were detected in 21 of the 337 patients
(6%) and were more prevalent (18%) in those patients with
a high () cTn level (Table I). At 1 year after surgery, the
mortality rate was nonsignificantly higher for patients with
vs those without new ischemic ECG changes (14% vs 6%;
P  .18). All patients with an ischemic ECG tracing and
who died at 1 year after surgery had an elevated postoper-
ative cTn level (Fig 2). The presence of ischemic ECG
changes did not increase the long-termmortality risk in any
of the troponin subsets (Fig 3).
Cox proportional-hazards model. As shown in Fig
4, independent predictors of long-term mortality after vas-
cular surgery were age (OR, 1.05; 95% CI, 1.02-1.07; P
.01), stratified troponin (OR, 1.62; 95% CI, 1.25-2.10;
Table I. Baseline clinical variables according to troponin l
Variablea
Negative
(n  202)
Age, years 68  8
Hyperlipidemia 158 (78)
Insulin-dependent DM 15 (7)
Chronic kidney disease 18 (9)
Cerebrovascular disease 53 (26)
COPD 47 (23)
Coronary artery disease 87 (43)
Prior
Myocardial infarction 43 (21)
Congestive heart failure 13 (6)
RCRI score 1.9  0.7
RCRI variables present
1 59 (29)
2 99 (49)
3 44 (22)
Abnormal pre-op SPECTb 53 (26)
Perfusion defect
Reversible 37 (18)
Fixed 21 (10)
Moderate or large 25 (12)
Urgent or emergency 27 (13)
Open AAA repair 33 (16)
EVAR 82 (40)
Infrainguinal PAD 37 (18)
Carotid surgery 50 (24)
Tissue loss 11 (5)
Ischemic ECG changes 6 (3)
Medications
Aspirin 157 (77)
-blockers 124 (61)
Statins 145 (71)
AAA, Abdominal aortic aneurysm; COPD, chronic obstructive pulmonary d
disease; RCRI, revised cardiac risk index; SPECT, single-photon emission c
aContinuous data are presented as mean  standard deviation, and categori
bAbnormal SPECT refers to reversible and fixed perfusion defects. Some pati
perfusion defects exceeds the total number of abnormal SPECTs.P .01), tissue loss (OR, 3.30; 95%CI, 1.72-6.33; P .01), htratified RCRI (OR, 1.32; 95% CI, 0.97-1.81; P  .07),
nd statin use (OR, 0.62; 95% CI, 0.40-0.98; P  .04).
rgent and emergency operations, abnormal preoperative
PECT, ischemia on ECG, and aortic cross-clamp opera-
ions were not included in the model.
ISCUSSION
The principal finding of this study is that an elevated
roponin level after vascular surgery predicts late mortality
nd that the addition of the ECG for identifying high-risk
atients after surgery does not add additional prognostic
nformation beyond that supplied by peak cTn elevation.
lthough the diagnosis of MI may be dependent on one or
ore correlates of myocardial ischemia, including the use
f the ECG as a means of detecting ischemia, the absence of
hose clinical variables does notminimize the importance of
rise and fall of the troponin level as an independent
redictor of death.
In the present study, biochemical evidence of myocar-
ial ischemia or necrosis, or both, as determined by a cTn
evel above the URL of the specific assay, was observed in a
(N  337)
Low () High ()
P(n  82) (n  53)
69  8 71  9 .01
63 (76) 44 (83) .67
6 (7) 7 (13) .37
22 (21) 16 (20) .008
26 (31) 8 (15) .09
21 (25) 14 (26) .85
44 (53) 34 (64) .01
21 (25) 19 (35) .01
13 (15) 12 (22) .01
2.1  0.7 2.4  0.7 .01
.02
16 (20) 8 (15)
38 (46) 24 (45)
28 (34) 21 (40)
28 (34) 33 (62) .01
20 (24) 24 (45) .01
18 (22) 17 (32) .01
20 (24) 21 (40) .01
9 (11) 13 (24) .07
21 (25) 17 (32) .02
28 (34) 14 (26) .13
13 (16) 15 (28) .17
20 (24) 7 (13) .19
6 (5) 5 (9) .49
5 (6) 10 (18) .01
67 (81) 34 (62) .05
53 (64) 39 (73) .25
60 (73) 35 (66) .64
; DM, diabetes mellitus; ECG, electrocardiogram; PAD, peripheral arterial
ted tomography.
as number (%).
ve both types of defect and that explains why the sum of reversible and fixedevels
isease
ompu
c dataigh percentage (40%) of patients undergoing vascular
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Volume 57, Number 1 Garcia et al 169urgery. In contrast, only a fraction of the study cohort
6%) had evidence of myocardial ischemia on a postopera-
ive ECG tracing. Even among those patients with an
levated troponin level, less than one in four had evidence
f myocardial ischemia on ECG. Conversely, all of the
atients with ischemic ECG changes and who died1 year
fter vascular surgery had an elevated cTn after surgery. The
ndings from the logistic regression mode show that a low
) and a high () cTn elevation were both predictors of
-year mortality, whereas the presence of an ischemic ECG,
ndependent of the cTn level, was not predictive of long-
erm outcomes.
The most recent American College of Cardiology/
c troponin I (cTnI) after vascular surgery. Normal cTnI
(orange line, group 2). SE, Standard error.
ig 3. One-year mortality after vascular surgery was assessed rel-
tive to postoperative troponin status and ischemic electrocardio-
raphic changes. Results were not statistically significant.Fig 1. Kaplan-Meier survival curves according to peak cardiaFig 2. Flow chart describes survival status 1 year after vascular
surgery as it relates to postoperative ischemic electrocardiographicTable II. Postoperative, 1-year, and 2.5-year mortality
according to peak cTn levels (N  337)
Mortality
Negative Low () High ()
P
(n  202) (n  82) (n  53)
No. (%) No. (%) No. (%)
30 days 2 (1) 1 (1) 1 (2) .86
1 year 6 (3) 9 (11) 9 (17) .01
2.5 years 14 (7) 13 (16) 15 (28) .01merican Heart Association perioperative guidelines state
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have known or suspected coronary artery disease undergo-
ing high-risk or intermediate-risk surgical procedures, per-
forming an ECG at baseline, immediately after the surgical
procedure, and daily on the first 2 days after surgery appears
to be the most cost-effective strategy for detecting periop-
erative MI.21 Our results indicate that a strategy of system-
atic surveillance of postoperative cardiac events based on
the peak postoperative cTn level provides more rationale
because of the higher degree of sensitivity and the im-
proved accuracy to predict long-term death compared with
the results of postoperative 12-lead ECG tracings alone.
The findings from the present study are consistent with
those from Rinfret et al,22 who reviewed outcomes in 3570
patients undergoing major noncardiac surgery and found
that 8% had evidence of myocardial ischemia postopera-
tively. As with our study findings, those authors showed
that the incidence of a major postoperative cardiac compli-
cation was higher in patients with ischemic ECG changes
than in those without ECG changes (7% vs 2%).22 Because
data involving biomarker elevations were not available in
their study, whether additional prognostic information
would have proved beneficial for predicting long-term risk
of death is unclear.
Using a different strategy involving ECG tracings, Bot-
tiger et al8 investigated 55 patients undergoing noncardiac
surgery and found that continuous 3-channel Holter mon-
itoring was more sensitive than intermittent 12-lead ECG
recordings for the detection of myocardial ischemia (53% vs
44%).8 However, the concordance of abnormalities on the
Holter monitor with elevations in troponin I was modest
and was reported to be 70%.
Unlike a spontaneous MI, in which patients present
with sudden onset of chest pain as a result of a ruptured
plaque in the coronary artery,23 the pathophysiology of a
postoperative MI is unclear and may result from an imbal-
ance between oxygen supply and demand.2 Several studies
Fig 4. Clinical predictors of long-term mortality afte
regression analysis. RCRI, Revised Cardiac Risk Index.that used continuous ECG monitoring in high-risk iascular patients undergoing surgery indicated that
achycardia-related ST-segment depression is common in the
ostoperative period and that these events predict those
ndividuals at increased risk of short-term and long-term
ortality.5,6 Landesberg et al6 showed that the peak tro-
onin elevation, used as a surrogate marker for myocardial
amage, correlates well with the duration of ST-segment
epression.
The specific clinical conditions that trigger an elevated
roponin level during the postoperative period are complex
ut are likely related to increased adrenergic stimula-
ion.24,25 In fact, the magnitude of the rise in cat-
cholamines is higher among patients with elevated tro-
onin levels,26 which would suggest an association
etween the sympathetic system and myocardial necrosis,
ith a supply-and-demandmismatch that is likely mediated
y wide fluctuations in heart rate, diastolic perfusion pres-
ure, and myocardial wall stress. Nearly 90% of ischemic
vents detected by Holter monitoring occur in the operat-
ng or recovery rooms at a time that postoperative hemo-
ynamic conditions are most unstable.8 Because continu-
us ECG monitoring may not be available during these
ulnerable periods, the low predictive accuracy of the 12-
ead ECG as a means of detecting ischemic events is not
urprising.
After noncardiac operations, when adverse cardiac
vents are likely to be clinically subtle, the value of a rise and
all of a specific cardiac biomarker for predicting long-term
utcomes is a critical tool. Our study results show that
ystematic surveillance of peak cTn levels should be a strong
onsideration for optimal risk stratification after high-risk
oncardiac operations such as vascular surgery. The incre-
ental value of looking for ECG changes, as a means of
etecting clinical correlates of ischemia, can grossly under-
stimate those patients at increased risk of death, and the
CG by itself provides no incremental value in predicting
utcomes in this specific population with vascular disease,
ular surgery are shown in Cox proportional hazardsr vascndependent of the biomarker. Our practice is to routinely
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tion every 8 hours for the first 24 hours. Among patients
with a rise and fall in cTn, a cardiac consultation is obtained
for optimization of medical therapies and to guide selection
of cardiac imaging.
Our study has several limitations that are worth noting.
First, we have limited information regarding adequacy of
risk factors control after the vascular operation, which is an
important determinant of long-term mortality. Second, we
are unable to provide cause-specific mortality data. Third,
we only included patients with complete biomarker and
electrocardiographic data. We cannot exclude the possibil-
ity of selection bias, whereby lower-risk patients, in whom
cTns were not measured, were excluded. Finally, all pa-
tients in our cohort were men. Caution is required when
extrapolating these results to women.
CONCLUSIONS
The optimal means of risk stratifying patients in the
postoperative period, after high-risk noncardiac operations,
must include surveillance of specific cardiac biomarkers
within the first 48 hours after surgery. Although the addi-
tion of the ECG may provide supplementary information
about an associated clinical correlate of ischemia, the low
sensitivity of the ECG for identifying patients at increased
risk of death limits its utility in clinical practice.
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